STOCK TITAN

Marpai Inc Stock Price, News & Analysis

MRAI Nasdaq

Welcome to our dedicated page for Marpai news (Ticker: MRAI), a resource for investors and traders seeking the latest updates and insights on Marpai stock.

Marpai Inc (NASDAQ: MRAI) delivers AI-powered Third-Party Administration services for self-funded health plans, combining deep learning with healthcare cost management. This news hub provides investors and benefits professionals with essential updates on the company's operational developments and strategic initiatives.

Access comprehensive coverage of Marpai's financial announcements, technology advancements, and partnership updates. Our curated news collection features press releases detailing cost-containment programs, artificial intelligence implementations, and service expansions within the $22 billion TPA market.

Key updates include earnings reports, leadership changes, predictive analytics breakthroughs, and network expansions. The repository serves as a centralized source for tracking Marpai's progress in reducing employer healthcare costs through machine learning applications and operational optimizations.

Bookmark this page for real-time updates on Marpai's initiatives in healthcare AI and benefits administration. Regularly refreshed content ensures stakeholders maintain current understanding of the company's market position and technological innovations in the evolving TPA sector.

Rhea-AI Summary

Marpai, Inc. (Nasdaq: MRAI) reported a 23% increase in revenue for Q4 2021, totaling approximately $5.9 million compared to $4.8 million in Q3 2021. For the full year ended December 31, 2021, revenue reached about $14.2 million, fueled by the acquisition of Continental Benefits. However, operating expenses surged to around $11.6 million in Q4, leading to a net loss of approximately $5.7 million. Marpai anticipates Q1 2022 revenue between $6 million and $6.2 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.33%
Tags
none
-
Rhea-AI Summary

Marpai, Inc. (Nasdaq: MRAI), an AI-focused health plan services provider, will present at the 2022 Virtual Growth Conference hosted by Maxim Group LLC from March 28-30. CEO Edmundo Gonzalez is scheduled for a fireside chat on March 29 from 9:00-9:30 AM ET. The conference showcases over 200 companies across various sectors, including Healthcare and Technology. Marpai's services target the $22B Third-Party Administrator market, focusing on reducing claims costs and improving healthcare outcomes using AI algorithms. For more details, visit www.marpaihealth.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.98%
Tags
conferences
-
Rhea-AI Summary

Marpai (Nasdaq: MRAI), a deep learning technology company, will host a conference call on March 31, 2022, at 8:30 a.m. ET to discuss its fourth quarter and full year financial results for 2021. The results will be reported after trading on March 30, 2022. Marpai aims to transform third-party administration in the self-funded health insurance market, leveraging AI to optimize health plan services, which potentially impacts over $1T in annual healthcare claims. The call provides an opportunity to gain insights into Marpai's operational and financial performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.39%
Tags
conferences earnings
Rhea-AI Summary

Marpai, Inc. (Nasdaq: MRAI) has appointed Lutz Finger, former Google Group Product Manager in healthcare analytics, as its President of Product and Development. Finger, with over 20 years of experience, will spearhead product management and development strategies aimed at enhancing the efficiency of Marpai's services in the $22B Third-Party Administrator market. His leadership is expected to drive innovative, AI-powered solutions that lower healthcare costs and improve health outcomes for members, starting February 28, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.18%
Tags
none
-
Rhea-AI Summary

Marpai, Inc. (NASDAQ: MRAI) announced preliminary fourth-quarter 2021 revenues expected between $5.7 million and $5.9 million, surpassing prior guidance of $5.6 million to $5.8 million, indicating approximately 19% to 23% growth from Q3 2021. As of December 31, 2021, the company reported $19.2 million in cash and cash equivalents. Full audited financial results are anticipated by March 31, 2022. Marpai offers AI-driven TPA services in the $22 billion market, improving healthcare management for employers and impacting over $1 trillion in healthcare claims annually.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.07%
Tags
none
-
Rhea-AI Summary

Marpai, Inc. (Nasdaq: MRAI), a deep learning technology company, has launched AI-powered services to improve employer health plans, aiming to reduce health claims costs and enhance care quality for over 156 million Americans. The self-funded employer market, representing more than $1 trillion in claims annually, is targeted for these services. CEO Edmundo Gonzalez states the goal is to slash costs in half using advanced AI, supported by tech-enabled offerings like Marpai Cares and the MyMarpai SMART App. Marpai's innovative approach promises significant changes in handling rising health plan expenses.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.14%
Tags
none
Rhea-AI Summary

Marpai, Inc. (Nasdaq: MRAI) has launched Marpai Cares, an AI-powered proactive health service aimed at enhancing patient outcomes in self-funded health insurance. This service leverages deep learning to identify and address health issues linked to chronic diseases like diabetes and cardiovascular problems. Licensed clinicians from MedWatch assist members in navigating their care journeys. Marpai serves over 40,000 members across 60+ employers, positioning itself as a leading alternative in the $1T self-funded health insurance market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.76%
Tags
none
-
Rhea-AI Summary

Marpai, Inc. (NASDAQ: MRAI), a leader in deep learning technology for self-funded health insurance, will feature CEO Edmundo Gonzalez on The RedChip Money Report® airing on Bloomberg TV on January 8 at 7 p.m. ET. This engagement offers exposure to an audience of approximately 73 million households across the U.S. Marpai strives to reduce healthcare costs and improve outcomes through AI innovations, currently serving over 60 companies and 40,000 members nationwide. Forward-looking statements in the release suggest potential risks concerning market conditions and business growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.16%
Tags
none
-
Rhea-AI Summary

Marpai, Inc. (Nasdaq: MRAI) is expanding into the education market by establishing a center of excellence to enhance health plan services for school districts. Currently, Marpai is serving four Texas school districts, impacting 39 schools. The company's AI-driven services aim to improve member health and reduce costs, utilizing predictive deep learning to guide members to quality care and prevent costly health events. Collaborating with Synolo and USEBSG, Marpai's initiative emphasizes a proactive approach to healthcare for educators and their families.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.8%
Tags
none
Rhea-AI Summary

Marpai, Inc. (NASDAQ: MRAI) announced that its management and directors have collectively purchased $1.1 million in common stock. Board member Damien Lamendola increased his holdings, acquiring 225,000 warrants at $4 per share, injecting an additional $900,000 into the company. Notable purchases include 25,000 shares by Chairman Yaron Eitan and 17,500 shares by CEO Edmundo Gonzalez, with prices ranging from $4.17 to $4.42 per share. These actions reflect confidence in Marpai's AI-driven solutions in the self-funded health insurance market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.66%
Tags
none

FAQ

What is the current stock price of Marpai (MRAI)?

The current stock price of Marpai (MRAI) is $1.05 as of May 2, 2025.

What is the market cap of Marpai (MRAI)?

The market cap of Marpai (MRAI) is approximately 6.7M.
Marpai Inc

Nasdaq:MRAI

MRAI Rankings

MRAI Stock Data

6.70M
4.05M
52.56%
13.12%
0.16%
Healthcare Plans
Services-misc Health & Allied Services, Nec
Link
United States
TAMPA